| scholarly article | Q13442814 |
| P2093 | author name string | Sony Maharjan | |
| Su In Lee | |||
| Byoung Kwon Park | |||
| Hyung-Joo Kwon | |||
| Keunwook Lee | |||
| Yoonho Lim | |||
| P2860 | cites work | The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention | Q21245733 |
| Cyclin D as a therapeutic target in cancer | Q28242623 | ||
| Triple-Negative Breast Cancer | Q29391607 | ||
| Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants | Q33915057 | ||
| Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer | Q34058510 | ||
| Breast cancer: challenges, controversies, breakthroughs. | Q51775452 | ||
| Cyclin D1 protein expression and function in human breast cancer | Q58883578 | ||
| Prognostic role of cyclin D1 in lung cancer. Relationship to proliferating cell nuclear antigen | Q74665364 | ||
| Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans | Q82961573 | ||
| Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. | Q34184917 | ||
| Triple-negative breast cancer: clinical features and patterns of recurrence | Q34658655 | ||
| RB1 status in triple negative breast cancer cells dictates response to radiation treatment and selective therapeutic drugs | Q35050328 | ||
| Anti-inflammatory effect of heme oxygenase-1 toward Porphyromonas gingivalis lipopolysaccharide in macrophages exposed to gomisins A, G, and J. | Q35588216 | ||
| Perturbations of the AKT signaling pathway in human cancer | Q36313181 | ||
| Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer | Q36495792 | ||
| Cyclins and cell cycle control in cancer and disease | Q36796438 | ||
| Columbianadin Inhibits Cell Proliferation by Inducing Apoptosis and Necroptosis in HCT116 Colon Cancer Cells | Q36879208 | ||
| Triple-negative breast cancer: treatment challenges and solutions | Q36940085 | ||
| The Effect of (1S,2S,3E,7E,11E)-3,7,11,15-Cembratetraen-17,2-Olide (LS-1) from Lobophyyum sp. on the Apoptosis Induction of SNU-C5 Human Colorectal Cancer Cells | Q37397903 | ||
| The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. | Q37454384 | ||
| Schisandra chinensis prevents alcohol-induced fatty liver disease in rats | Q37512959 | ||
| Gomisin N inhibits adipogenesis and prevents high-fat diet-induced obesity | Q37571335 | ||
| Cell cycle proteins as promising targets in cancer therapy | Q37693690 | ||
| Understanding the biology of triple-negative breast cancer | Q38046574 | ||
| Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment | Q38458999 | ||
| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study | Q38787080 | ||
| Cyclin D1, cancer progression, and opportunities in cancer treatment. | Q38970431 | ||
| Anti-inflammatory effects of gomisin N, gomisin J, and schisandrin C isolated from the fruit of Schisandra chinensis | Q39742409 | ||
| Antiproliferative effects of dibenzocyclooctadiene lignans isolated from Schisandra chinensis in human cancer cells | Q40038703 | ||
| Drug-drug interation prediction between ketoconazole and anti-liver cancer drug Gomisin G | Q40782905 | ||
| Anti-AIDS agents--XXVI. Structure-activity correlations of gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues | Q41095724 | ||
| Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination | Q45158123 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P2507 | corrigendum / erratum | Erratum to "Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1" [Biomol.Ther. 26 (2018) 322-327] | Q58775619 |
| P433 | issue | 3 | |
| P921 | main subject | phosphorylation | Q242736 |
| triple-negative breast cancer | Q7843332 | ||
| P304 | page(s) | 322-327 | |
| P577 | publication date | 2018-03-28 | |
| P1433 | published in | Biomolecules & therapeutics | Q20020559 |
| P1476 | title | Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1. | |
| P478 | volume | 26 |
| Q64917760 | A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model. |
| Q92726527 | CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo |
| Q92655292 | Decursinol Angelate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Modulating Type 17 Helper T Cell Responses |
| Q57790134 | Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex |
| Q89105507 | Gomisin G Suppresses the Growth of Colon Cancer Cells by Attenuation of AKT Phosphorylation and Arrest of Cell Cycle Progression |
| Q64255577 | Potential of (Turcz.) Baill. in Human Health and Nutrition: A Review of Current Knowledge and Therapeutic Perspectives |
| Q58775619 | Erratum to "Gomisin G Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing AKT Phosphorylation and Decreasing Cyclin D1" [Biomol.Ther. 26 (2018) 322-327] | main subject | P921 |
Search more.